House urges FDA action on drug shortages

More than 90 members of the U.S. House of Representatives sent a letter to the FDA urging it to take swift action to combat drug shortages.

Advertisement

In urging action from the FDA,the representatives note that there were 186 new drug shortages last year, a 27 percent increase from 2017 and the highest amount of drug shortages seen throughout the last five years.

The FDA created a Drug Shortage Task Force in 2018 to find the root cause of drug shortages and propose solutions.The task force was supposed to submit a detailed report to Congress; however, the report has yet to be seen, the lawmakers wrote in the letter.

The letter requested the FDA respond promptly and gives Congress a timeline on when the report would be submitted outlining steps to take to fix the drug shortage problem.

Read the letter here

More articles on supply chain:

Prior authorizations making it ‘as difficult as possible’ for patients to get necessary medical supplies

Beaumont Health sells home medical equipment business

FDA warns of more device shortages linked to sterilization plant closure

At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.

Register to Attend Webinar

From fragmentation to operational flow: Solving the healthcare workforce puzzle

Tuesday, August 11
1:00 PM - 2:00 PM CDT

Presenters: Dr. Pat Hunt, QGendaAndrea Daugherty, MHA, CISSP, CHCIO, CDH-E, Arrowhead Regional Medical CenterElizabeth Lindsay-Wood, MBA, CHCIO, CDH-E, Moffitt Cancer CenterDeb Muro, El Camino HealthJohn Tejeda, D.H.A., MLS, MPAS, DFAAPA, LSSBB, FACHE, Vascular and Neuroscience Institute

Advertisement

Next Up in Supply Chain

Advertisement

Comments are closed.